Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06535399
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
Study to Assess Drug Levels and Safety of Golcadomide BMS-986369 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Multi-center Open-label Single-dose Study to Assess the Pharmacokinetics and Safety of Golcadomide BMS-986369 in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the drug levels and safety of golcadomide BMS-986369 in adult participants with moderate and severe Hepatic Impairment HI and in matched healthy control participants with normal hepatic function
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None